Wealth Effects »

Seelos Therapeutics Ord shares owned by Wealth Effects

Quarter-by-quarter ownership of Seelos Therapeutics Ord (SEEL) shares owned by Wealth Effects from 13F filings

Historical chart of Wealth Effects investment in Seelos Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Seelos Therapeutics Ord held by Wealth Effects consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seelos Therapeutics Ord by Wealth Effects

Quarter filed Position value Share count Share price at filing
2024-03-31 $276k 467k 0.59
2023-12-31 $318k 229k 1.39

More positions owned by Wealth Effects

Avadel Pharmaceuticals Sponsored Adr (AVDL)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
JPMorgan Chase & Co. (JPM)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
The Trade Desk Com Cl A (TTD)
Arrowhead Pharmaceuticals (ARWR)
Blackstone Group Inc Com Cl A (BX)
Ishares Tr Core S&p500 Etf (IVV)
International Business Machines (IBM)
Chevron Corporation (CVX)

View all positions for Wealth Effects

Top funds holding Seelos Therapeutics Ord

Wealth Effects
Vanguard Group
Balyasny Asset Management
Jeffrey L. Gendell
Modera Wealth Management
Citadel Advisors
Lynwood Capital Management
Strategic Family Wealth Counselors
Two Sigma Investments
CRA Financial Services
Wealth Enhancement Advisory Services
Advisor Group Holdings
Carmichael Hill & Associates
Bank of America Corporation
Jpmorgan Chase & Co

View all funds holding Seelos Therapeutics Ord